Executive Update

Dear Colleague,

A recent Wolters Kluwer, Health division survey revealed that 46 percent of U.S. hospital executives and clinicians identified “avoiding medication errors that cause patient harm” as their leading challenge. We also learned more than 86 percent of clinicians said there are too many clinical alerts that are not relevant to what they need for their patients.

Expert solutions, dedicated teams and regulations are often put in place to try to drive improvements around these challenges. I want to share with you some of the industry news and research that we’ve been following as my team makes plans for enhancing our clinical surveillance and compliance solutions in 2020. Our mission is to ensure every patient benefits from the best knowledge and evidence to improve their care.

  • +Last month CMS finalized its regulations that require U.S. hospitals to implement Antimicrobial Stewardship programs. This was announced on the heels of CDC’s 2018 Antibiotic Use in the U.S. progress report that showed approximately 30 percent of antibiotics used in hospitals are unnecessary. Healthcare providers have made significant strides forward to improve antibiotic prescribing and use, but many opportunities remain. That’s why we’re announcing Sentri7® Antimicrobial Stewardship (AMS) solution enhancements at ASHP Midyear in December. This includes Standardized Antibiotic Administrative Ratio (SAAR) benchmarking capabilities, improved detection of C. difficile via risk scoring, as well as additional rules content, analytics and reporting. Watch your email for more information about how to learn more at ASHP. If you are interested in attending a small group best practice session on AMS facilitated by our clinical team, please contact your Customer Success Manager.
  • + In September, the United States Pharmacopeia (USP) postponed the enforcement for USP Chapters <795> and <797> due to appeals. Nevertheless, our Compliance Solutions team continues to work with our experts, like Eric S. Kastango, MBA, BSPharm, FASHP (President & CEO, Clinical IQ and CriticalPoint) to make it easier for you to meet both sets of requirements when the time comes. Eric reminded us why it’s important that we all keep moving forward, “While these regulations are temporarily on hold, <797> (2008) and <795> (2014) versions will be enforced by state boards of pharmacy, the FDA and the Joint Commission. It’s so much more than about passing an inspection—it all boils down to keeping patients and staff safe. That is the priority.” We couldn’t agree more. With Simplifi 797®, you can be confident that you have the tools, tasks and training to keep your staff and patients safe and avoid costly penalties. Check our recent Webinar to learn more> and see the full announcement from USP here.
  • + Government regulation around sepsis care is one way states are trying to standardize care for conditions that have a significant impact on patient lives and cost of care. A recent JAMA study states that sepsis legislation in New York led to a significant decrease in sepsis mortality, falling from 26.3 percent to 22 percent. The regulations mandated that hospitals implement evidence-based protocols for sepsis, and report protocol adherence and outcomes. We saw similar Indiana legislation in June, making it the fourth state with legislation to improve sepsis diagnosis and care, joining New York, New Jersey and Illinois. There are ways to improve your hospital’s sepsis initiative performance—it requires a dedicated hospital team and a solution that can identify sepsis early, when every minute counts. Our client, Guthrie, an integrated health care system, is using POC Advisor’s artificial intelligence (AI) capabilities to do just that. If you can quickly find these patients, you can improve care and outcomes, including length of stay and mortality. Read more>


Our product innovation plans—whether it’s a feature release to an existing solution like Sentri7  or Simplifi 797 or a new product like POC Advisor—are designed to help you stay ahead of health care challenges like these and emerging requirements. If you want to learn more about how our solutions can help you navigate these challenges in the marketplace, contact your dedicated Customer Success Manager or our Support team (800-341-0450 or support@pharmacyonesource.com).



Karen Kobelski,

General Manager, Clinical Surveillance & Compliance